Genetic and Transcriptional Control of Bone Formation

Oral and Maxillofacial Surgery Clinics of North America

Volumn 22, Issue 3, 2010, Pages 283-293

  Javed, Amjad ^a   Chen, Haiyan ^a   Ghori, Farah Y ^b  

^a Univ of Alabama School of Dentistry   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Bone development; Molecular signaling; Osteoblast; Skeletal remodeling

Indexed keywords

TRANSCRIPTION FACTOR;

BONE DEVELOPMENT; BONE REMODELING; CELL DIFFERENTIATION; CELL LINEAGE; GENETIC TRANSCRIPTION; GENETICS; HUMAN; JAW; MESENCHYMAL STEM CELL; OSTEOBLAST; OSTEOCLAST; PHYSIOLOGY; PRENATAL DEVELOPMENT; REVIEW; SIGNAL TRANSDUCTION;

ALVEOLAR PROCESS; BONE DEVELOPMENT; BONE REMODELING; CELL DIFFERENTIATION; CELL LINEAGE; HUMANS; MESENCHYMAL STEM CELLS; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 77955735536     PISSN: 10423699     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coms.2010.05.001     Document Type: Review

References (88)

1. Shubin N.H., Alberch P.A. Morphogenic approach to the origin and basic organization of the tetrapod limb. Evol Biol 1986, 20:319-387.
2. Osumi-Yamashita N., Ninomiya Y., Eto K., et al. The contribution of both forebrain and midbrain crest cells to the mesenchyme in the frontonasal mass of mouse embryos. Dev Biol 1994, 164(2):409-419.
3. Sodek J., McKee M.D. Molecular and cellular biology of alveolar bone. Periodontol 2000 2000, 24:99-126.
4. Zernik J.H., Nowroozi N., Liu Y.H., et al. Development, maturation, and aging of the alveolar bone. New insights. Dent Clin North Am 1997, 41(1):1-15.
5. Chai Y., Jiang X., Ito Y., et al. Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development 2000, 127:1671-1679.
6. Thesleff I., Aberg T. Molecular regulation of tooth development. Bone 1999, 25(1):123-125.
7. Ducy P., Schinke T., Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science 2000, 289(5484):1501-1504.
8. Karsenty G. Transcriptional control of skeletogenesis. Annu Rev Genomics Hum Genet 2008, 9:183-196.
9. Lian J.B., Javed A., Zaidi S.K., et al. Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors. Crit Rev Eukaryot Gene Expr 2004, 14(1-2):1-41.
10. Stein G.S., Lian J.B. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 1993, 14(4):424-442.
11. Aubin J.E. Regulation of osteoblast formation and function. Rev Endocr Metab Disord 2001, 2(1):81-94.
12. de Crombrugghe B., Lefebvre V., Nakashima K. Regulatory mechanisms in the pathways of cartilage and bone formation. Curr Opin Cell Biol 2001, 13(6):721-727.
13. Karsenty G., Kronenberg H.M., Settembre C. Genetic control of bone formation. Annu Rev Cell Dev Biol 2009, 25:629-648.
14. Gronthos S., Zannettino A.C., Graves S.E., et al. Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells. J Bone Miner Res 1999, 14(1):47-56.
15. Canalis E., Delany A.M. Mechanisms of glucocorticoid action in bone. Ann N Y Acad Sci 2002, 966:73-81.
16. Nijweide P.J., Burger E.H., Feyen J.H. Cells of bone: proliferation, differentiation, and hormonal regulation. Physiol Rev 1986, 66(4):855-886.
17. Suda T., Udagawa N., Nakamura I., et al. Modulation of osteoclast differentiation by local factors. Bone 1995, 17(Suppl 2):87S-91S.
18. Kronenberg H.M. PTHrP and skeletal development. Ann N Y Acad Sci 2006, 1068:1-13.
19. Jilka R.L., O'Brien C.A., Ali A.A., et al. Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts. Bone 2009, 44(2):275-286.
20. Parfitt A.M. Parathyroid hormone and periosteal bone expansion. J Bone Miner Res 2002, 17(10):1741-1743.
21. Kato S., Suzawa M., Takada I., et al. The function of nuclear receptors in bone tissues. J Bone Miner Metab 2003, 21(6):323-336.
22. Canalis E. Update in new anabolic therapies for osteoporosis. J Clin Endocrinol Metab 2010, 95(4):1496-1504.
23. Jensen E.D., Gopalakrishnan R., Westendorf J.J. Regulation of gene expression in osteoblasts. Biofactors 2010, 36(1):25-32.
24. Damsky C.H. Extracellular matrix-integrin interactions in osteoblast function and tissue remodeling. Bone 1999, 25(1):95-96.
25. Franceschi R.T., Xiao G. Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways. J Cell Biochem 2003, 88(3):446-454.
26. Stupack D.G., Cheresh D.A. Get a ligand, get a life: integrins, signaling and cell survival. J Cell Sci 2002, 115(Pt 19):3729-3738.
27. Cheresh D.A., Stupack D.G. Integrin-mediated death: an explanation of the integrin-knockout phenotype?. Nat Med 2002, 8(3):193-194.
28. Boskey A.L., Wright T.M., Blank R.D. Collagen and bone strength. J Bone Miner Res 1999, 14(3):330-335.
29. Glimcher M.J. Mechanism of calcification: role of collagen fibrils and collagen-phosphoprotein complexes in vitro and in vivo. Anat Rec 1989, 224(2):139-153.
30. Gericke A., Qin C., Sun Y., et al. Different forms of DMP1 play distinct roles in mineralization. J Dent Res 2010, 89(4):355-359.
31. Robey P.G. Bone proteoglycans and glycoproteins. Principal of bone biology 2002, 225-238. Academic Press, San Diego (CA). J.P. Bilezikian, L.A. Raisz, G.A. Rodan (Eds.).
32. Xing L., Boyce B.F. Regulation of apoptosis in osteoclasts and osteoblast cells. Biochem Biophys Res Commun 2005, 328(3):709-720.
33. Jilka R.L., Weinstein R.S., Bellido T., et al. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res 1998, 13(5):793-802.
34. Lynch M.P., Capparelli C., Stein J.L., et al. Apoptosis during bone-like tissue development in vitro. J Cell Biochem 1998, 68(1):31-49.
35. Dallas S.L., Bonewald L.F. Dynamics of the transition from osteoblast to osteocyte. Ann N Y Acad Sci 2010, 1192(1):437-443.
36. Bonewald L.F., Johnson M.L. Osteocytes, mechanosensing and Wnt signaling. Bone 2008, 42(4):606-615.
37. Watt F.M., Hogan B.L. Out of Eden: stem cells and their niches. Science 2000, 287(5457):1427-1430.
38. Slack J.M. Stem cells in epithelial tissues. Science 2000, 287:1431-1433.
39. McKay R. Stem cells in the central nervous system. Science 1997, 276:66-71.
40. da Silva Meirelles L., Nardi N.B. Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br J Haematol 2003, 123:702-711.
41. Wagers A.J., Weissman I.L. Plasticity of adult stem cells. Cell 2004, 116:639-648.
42. Graf T., Enver T. Forcing cells to change lineages. Nature 2009, 462(7273):587-594.
43. Belmonte J.C., Ellis J., Hochedlinger K., et al. Induced pluripotent stem cells and reprogramming: seeing the science through the hype. Nat Rev Genet 2009, 10(12):878-883.
44. Ebert A.D., Yu J., Rose F.F., et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009, 457:277-280.
45. Lee G., Papapetrou E.P., Kim H., et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 2009, 461:402-406.
46. Komori T., Yagi H., Nomura S., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
47. Mundlos S., Otto F., Mundlos C., et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 1997, 89:773-779.
48. Ducy P., Zhang R., Geoffroy V., et al. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997, 89:747-754.
49. Javed A., Gutierrez S., Montecino M., et al. Multiple Cbfa/AML sites in the rat osteocalcin promoter are required for basal and vitamin D-responsive transcription and contribute to chromatin organization. Mol Cell Biol 1999, 19(11):7491-7500.
50. Nakashima K., Zhou X., Kunkel G., et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17-29.
51. Javed A., Bae J.S., Afzal F., et al. Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal. J Biol Chem 2008, 283(13):8412-8422.
52. Gutierrez S., Javed A., Tennant D.K., et al. CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. J Biol Chem 2002, 277(2):1316-1323.
53. Yang X., Matsuda K., Bialek P., et al. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 2004, 117:387-398.
54. Kundu M., Javed A., Jeon J.P., et al. Cbfbeta interacts with Runx2 and has a critical role in bone development. Nat Genet 2002, 32(4):639-644.
55. Dobreva G., Chahrour M., Dautzenberg M., et al. SATB2 is amultifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell 2006, 125:971-986.
56. Koga T., Matsui Y., Asagiri M., et al. NFAT and Osterix cooperatively regulate bone formation. Nat Med 2005, 11:880-885.
57. Tribioli C., Lufkin T. The murine Bapx1 homeobox gene plays a critical role in embryonic development of the axial skeleton and spleen. Development 1999, 126:5699-5711.
58. Bialek P., Kern B., Yang X., et al. A twist code determines the onset of osteoblast differentiation. Dev Cell 2004, 6:423-435.
59. Javed A., Guo B., Hiebert S., et al. Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/PEBP2(alpha)) dependent activation of tissue-specific gene transcription. J Cell Sci 2000, 113(Pt 12):2221-2231.
60. Kim S., Koga T., Isobe M., et al. Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. Genes Dev 2003, 17:1979-1991.
61. Jones D.C., Wein M.N., Oukka M., et al. Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3. Science 2006, 312:1223-1227.
62. Li X., Huang M., Zheng H., et al. CHIP promotes Runx2 degradation and negatively regulates osteoblast differentiation. J Cell Biol 2008, 181(6):959-972.
63. Vega R.B., Matsuda K., Oh J., et al. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 2004, 119(4):555-566.
64. Ornitz D.M., Marie P.J. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 2002, 16(12):1446-1465.
65. Liu Z., Xu J., Colvin J.S., et al. Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev 2002, 16:859-869.
66. Kim H.J., Kim J.H., Bae S.C., et al. The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2. J Biol Chem 2003, 278(1):319-326.
67. Wu X., Shi W., Cao X. Multiplicity of BMP signaling in skeletal development. Ann N Y Acad Sci 2007, 1116:29-49.
68. Celil A.B., Campbell P.G. BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J Biol Chem 2005, 280(36):31353-31359.
69. Daluiski A., Engstrand T., Bahamonde M.E., et al. Bone morphogenetic protein-3 is a negative regulator of bone density. Nat Genet 2001, 27:84-88.
70. Kang J.S., Alliston T., Delston R., et al. Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3. EMBO J 2005, 24(14):2543-2555.
71. Day T.F., Guo X., Garrett-Beal L., et al. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 2005, 8:739-750.
72. Boyden L.M., Mao J., Belsky J., et al. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 2002, 346:1513-1521.
73. Bennett C.N., Longo K.A., Wright W.S., et al. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci U S A 2005, 102(9):3324-3329.
74. Maeda Y., Nakamura E., Nguyen M.T., et al. Indian hedgehog produced by postnatal chondrocytes is essential for maintaining a growth plate and trabecular bone. Proc Natl Acad Sci U S A 2007, 104:6382-6387.
75. Shimoyama A., Wada M., Ikeda F., et al. Ihh/Gli2 signaling promotes osteoblast differentiation by regulating Runx2 expression and function. Mol Biol Cell 2007, 18(7):2411-2418.
76. Hilton M.J., Tu X., Wu X., et al. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat Med 2008, 14:306-314.
77. Chorev M., Rosenblatt M. Parathyroid hormone: structure-function relations and analog design. Principles of bone biology 1996, 305-323. Academic Press, San Diego (CA). J.P. Bilezikian, L.G. Raisz, G.A. Rodan (Eds.).
78. Krishnan V., Moore T.L., Ma Y.L., et al. Parathyroid hormone bone anabolic action requires Cbfa1/Runx2-dependent signaling. Mol Endocrinol 2003, 17(3):423-435.
79. Bellido T., Ali A.A., Plotkin L.I., et al. Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism. J Biol Chem 2003, 278(50):50259-50272.
80. Tobimatsu T., Kaji H., Sowa H., et al. Parathyroid hormone increases beta-catenin levels through Smad3 in mouse osteoblast cells. Endocrinology 2006, 147(5):2583-2590.
81. Dusso A.S., Brown A.J. Mechanism of vitamin D action and its regulation. Am J Kidney Dis 1998, 32:S13-S24.
82. Sodek J. A comparison of the rates of synthesis and turnover of collagen and non-collagen proteins in adult rat periodontal tissues and skin using a microassay. Arch Oral Biol 1977, 22:655-665.
83. Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature 2003, 423:337-342.
84. Simonet W.S., Lacey D.L., Dunstan C.R., et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997, 89:309-319.
85. Kobayashi T., Narumiya S. Function of prostanoid receptors: studies on knockout mice. Prostaglandins Other Lipid Mediat 2002, 68-69:557-573.
86. Riggs B.L. The mechanisms of estrogen regulation of bone resorption. J Clin Invest 2000, 106(10):1203-1204.
87. Michael H., Härkönen P.L., Väänänen H.K., et al. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. J Bone Miner Res 2005, 20(12):2224-2232.
88. Chen Q., Kaji H., Kanatani M., et al. Testosterone increases osteoprotegerin mRNA expression in mouse osteoblast cells. Horm Metab Res 2004, 36(10):674-678.